Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2438]

ASCO 2021: No survival difference for frontline combination regimens in real world intermediate-risk and poor-risk clear cell RCC

ASCO 2021: No survival difference for frontline combination regimens in real world intermediate-risk and poor-risk...

ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-line immunotherapy in advanced bladder cancer

ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-line...

ASCO 2021: Post-surgery immunotherapy extends disease-free survival for select patients with kidney cancer

ASCO 2021: Post-surgery immunotherapy extends disease-free survival for select patients with kidney cancer

ASCO 2021: Targeted radiotherapy offers new treatment option for patients previously treated for metastatic castration-resistant prostate cancer

ASCO 2021: Targeted radiotherapy offers new treatment option for patients previously treated for metastatic...

Immunotherapy after surgery reduces deadly relapse risk in advanced bladder cancer

Immunotherapy after surgery reduces deadly relapse risk in advanced bladder cancer

When should screening start for men with a family history of prostate cancer?

When should screening start for men with a family history of prostate cancer?

Researchers identify new drug target for treating aggressive prostate cancer

Researchers identify new drug target for treating aggressive prostate cancer

Researchers identify new drug target for treating aggressive prostate cancer

Researchers identify new drug target for treating aggressive prostate cancer

New campaign launches to break down taboos around prostate cancer treatment side effects

New campaign launches to break down taboos around prostate cancer treatment side effects

New single-cell analysis tool links immune cells to kidney cancer recurrence

New single-cell analysis tool links immune cells to kidney cancer recurrence

More from ecancer